Pro Dex Inc (PDEX) stock

PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/304% below fair value

$67.42−4.07 (-5.69%)

Close on Nov 12, 2026Market cap $215.74MP/E 18.6Yield –

Pro Dex statistics

106 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Jan 28, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $215.74M; $501.02M
Enterprise Value: $215.03M; $422.54M
PE Ratio: 18.57; 29.97
PS Ratio: 2.71; 3.03
PB Ratio: 4.37; 3.29
P/TBV Ratio: 5.12; 4.85
P/FCF Ratio: 20.18; 26.37
P/OCF Ratio: 18.89; 22.12

Enterprise valuationIndustry

EV / Sales: 2.70; 2.70
EV / EBITDA: 14.45; 18.53
EV / EBIT: 16.05; 24.04
EV / FCF: 20.11; 27.78

Share statisticsIndustry

Shares Outstanding: 3M; 43M
Shares Change (YoY): -0.82%; 3.22%
Shares Change (QoQ): 0.54%; 0.16%
Float: 2M; 37M
Shares Held by Insiders: 45.7%; 10.5%
Shares Held by Institutions: 22.9%; 60.2%

Short sellingIndustry

Short Interest: 271,336; –
Short Interest Change: 15.0%; -2.57%
Short % of Float: 15.6%; 5.12%
Short % of Shares Outstanding: 8.48%; 3.98%
Days to Cover: 7.42; 3.94

Stock price statisticsIndustry

52-Week High: $77.00; –
52-Week Low: $28.81; –
20-Day Moving Average: $62.56; –
50-Day Moving Average: $64.96; –
200-Day Moving Average: $57.65; –
Average True Range (14): $3.49; –
Price Change (1 Week): 10.2%; 1.87%
Price Change (1 Month): 12.7%; -0.57%
Price Change (3 Months): 0.60%; -7.91%
Price Change (6 Months): 15.0%; -0.90%
Price Change (YTD): 75.2%; -0.87%
Price Change (1 Year): 100.6%; -1.18%
Price Change (3 Years): 276.5%; 6.56%
Price Change (5 Years): 189.9%; -49.8%
Price Change (10 Years): 1398.2%; 72.9%
Average Volume (10 Days): 40,674; –
Average Volume (20 Days): 38,701; –
Average Volume (90 Days): 69,878; –
Relative Volume: 0.32; 0.82
Relative Strength Index (14): 56.0; 47.7
Volatility (1 Year): 56.1%; 64.2%
Beta (5 Years): 0.26; 1.04

MarginsIndustry

Gross Margin: 32.5%; 55.9%
Operating Margin: 16.8%; -5.17%
Pretax Margin: 19.1%; -2.55%
Profit Margin: 15.1%; -9.23%
EBITDA Margin: 18.7%; -2.82%
FCF Margin: 13.4%; 0.40%

Returns on capitalIndustry

Return on Equity (ROE): 26.5%; -17.1%
Return on Assets (ROA): 17.1%; -12.2%
Return on Invested Capital (ROIC): 24.1%; -3.22%
Return on Capital Employed (ROCE): 21.0%; -8.13%

Financial positionIndustry

Current Ratio: 4.19; 2.45
Quick Ratio: 2.37; 1.53
Debt / Equity: 0.25; 0.42
Debt / EBITDA: 0.82; 2.19
Debt / FCF: 1.15; 3.62
Net Debt / EBITDA: -0.05; 1.53
Interest Coverage: 15.36; -1.68

GrowthIndustry

Revenue Growth (YoY): 13.3%; 9.24%
Net Income Growth (YoY): 7.49%; 13.4%
EPS Growth (YoY): 8.36%; 15.1%
Revenue Growth (3Y CAGR): 18.9%; 7.08%
Revenue Growth (5Y CAGR): 15.3%; 11.8%
EPS Growth (3Y CAGR): 28.3%; 3.11%
EPS Growth (5Y CAGR): 21.3%; 7.64%

EfficiencyIndustry

Asset Turnover: 1.13; 0.59
Inventory Turnover: 2.47; 2.20
Revenue Per Employee: $439.65K; $330.60K
Profits Per Employee: $66.46K; -$41.39K
Employee Count: 181; 186
WACC: 7.38%; 9.79%

Income statement (TTM)Industry

Revenue: $79.58M; $106.81M
Gross Profit: $25.82M; $62.29M
Operating Income: $13.40M; -$3.72M
Pretax Income: $15.17M; -$1.69M
Net Income: $12.03M; -$6.19M
EBITDA: $14.88M; -$1.98M
EPS (Diluted): $3.63; -$0.08

Balance sheetIndustry

Cash & Short-Term Investments: $12.99M; $38.08M
Total Debt: $12.27M; $96.00M
Net Cash (Debt): $719.00K; $3.73M
Net Cash Per Share: $0.22; $0.24
Equity (Book Value): $49.35M; $63.44M
Book Value Per Share: $15.42; $3.26
Tangible Book Value: $42.16M; $11.04M
Working Capital: $41.06M; $56.85M

Cash flow (TTM)Industry

Operating Cash Flow: $11.42M; -$541.49K
Capital Expenditures: -$731.00K; -$3.69M
Free Cash Flow: $10.69M; -$387.37K
FCF Per Share: $3.34; -$0.01

Dividends and yieldsIndustry

Earnings Yield: 5.58%; -4.70%
FCF Yield: 4.96%; 0.24%

Taxes and interestIndustry

Interest Expense: $872.00K; $5.33M
Income Tax: $3.14M; $1.63M
Effective Tax Rate: 20.7%; 18.3%

Scores and fair valueIndustry

Graham Number: $35.49; $38.11
Graham Upside: -47.4%; -56.6%
Altman Z-Score: 7.91; 2.44
Piotroski F-Score: 6; 5
Beneish M-Score: -2.56; -2.64
Lynch Fair Value: $77.26; –
Lynch Upside: 14.6%; -45.1%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	PDEX	S&P 500	Difference	PDEX per year	S&P 500 per year
1 month	+6.9%	-2.7%	+9.6 pts
3 months	+0.0%	-1.7%	+1.8 pts
Year to date	+75.2%	+11.9%	+63.3 pts
1 year	+107.6%	+12.0%	+95.6 pts
3 years	+272.1%	+78.2%	+193.9 pts	+55.0%	+21.2%
5 years	+189.9%	+73.2%	+116.6 pts	+23.7%	+11.6%
10 years	+1398.2%	+309.6%	+1088.6 pts	+31.1%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M PDEX shares were sold short on Oct 30, 2026, up 15.0% from the previous report, or 15.62% of the shares available to trade. At recent volumes it would take 7.4 days to buy them back. Over the last 20 sessions, 67.2% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	271,336	+15.0%	36,546	7.4
Oct 15, 2026	235,918	+18.3%	47,696	5.0
Sep 30, 2026	199,385	-5.0%	68,882	2.9
Sep 15, 2026	209,908	+17.4%	91,849	2.3
Aug 31, 2026	178,804	-7.9%	48,056	3.7
Aug 14, 2026	194,180	+13.7%	94,716	2.0
Jul 31, 2026	170,708	+8.7%	99,694	1.7
Jul 15, 2026	157,066	+5.7%	97,157	1.6
Jun 30, 2026	148,641	-10.0%	87,049	1.7
Jun 15, 2026	165,125	+14.7%	64,171	2.6
May 29, 2026	143,955	-24.6%	43,890	3.3
May 15, 2026	191,003	-19.1%	28,533	6.7